Report Highlights
The global market for diabetes monitoring devices is expected to grow from $16.6 billion in 2024 to $26.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.1% from 2024 through 2029.
Report Includes
- 30 data tables and 47 additional tables
- An analysis of the global market for diabetes care devices, including self-glucose monitoring devices and continuous glucose monitoring systems
- Analyses of global market trends, with market revenue data for 2021-2022, estimates for 2023 and 2024, and projected CAGRs through 2029
- Estimates of the market size and revenue prospects, along with a corresponding market share analysis by product type and sub-type, end user and region
- Discussion of the market potential and opportunities in the diabetes care industry, along with an analysis of the competitive environment, regulatory scenario and technological advances
- Facts and figures pertaining to R&D activity, industry-specific challenges, and the impact of macroeconomic factors
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
- Patent analysis featuring key granted and published patents
- New developments and clinical trials in the diabetes care market
- Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
- Profiles of leading companies, including Abbott, Medtronic, Dexcom Inc., F. Hoffmann-La Roche Ltd., and LifeScan IP Holdings LLC.
Report Scope
This report provides an analysis of the market for diabetes monitoring devices, along with a competitive landscape and profiles of key companies that include their revenues, product portfolios and recent activities. It analyzes trends and market dynamics, including drivers, limitations, challenges, and opportunities, and discusses historical, current and potential market size. The report will enable readers to make informed decisions about the production and licensing of goods and services, as well as market developments and trends. The study segments the market by product type, including self-monitoring blood glucose (SMBG) devices such as blood glucose meter devices, blood glucose test strips, lancets and lancet devices; and continuous glucose monitoring (CGM) device products, including transmitters and receivers. A regional market analysis, including country-level analysis, is provided for all segments. The report covers only diabetes monitoring devices; diabetes therapeutic devices, which include insulin delivery systems and any other equipment used in hospitals are outside the scope of the report.
Self-monitoring blood glucose (SMBG) devices:
- Blood glucose meter devices.
- Blood glucose test strips.
- Lancets and lancet devices.
Continuous glucose monitoring (CGM) systems:
- Sensors and transmitters.
- Receivers.
End users:
- Hospitals.
- Home care settings.
- Diagnostic centers.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2023 | ||||||||||||||||
| Forecast period considered | 2024-2029 | ||||||||||||||||
| Base year market size | $15.3 Billion | ||||||||||||||||
| Market size forecast | $26.8 Billion | ||||||||||||||||
| Growth rate | CAGR of 10.1% from 2024 to 2029 | ||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||
| Segments covered | Product Type and Sub-type, End User, and Region | ||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, South America, and the Rest of World (RoW) | ||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||
| Companies studied |
|
||||||||||||||||
Frequently Asked Questions (FAQs)
Analyst Credentials
Gundreddy Gopinadh– Associate Consultant-Life Sciences Research
Gopinadh is an experienced professional with nearly nine years in the market research industry and experience in research and analysis, specializing in medical devices, pharmaceuticals, biotechnology, and in-vitro diagnostics verticals. He is an expert in handling custom projects by gathering data points, analyzing market trends, and ultimately providing clients with accurate market size numbers, actionable insights, and recommendations based on their unique business needs. Academically, Gopinadh holds a master’s degree in biotechnology from VIT University.
Consulting Editor’s Credentials
Mariana Kuznietsova, a Life Science Consultant at BCC Research, has 8 years of experience in both academic and industry research developing biochemical and biotechnological applications and laboratory services. She also has a strong background in laboratory equipment trading services covering technical support, complex lab solutions to meet demands of laboratories from a range of areas, such as Academia, Agriculture, Pharma, and Food and Beverage. Mariana holds a Ph.D. in Biochemistry from the Taras Shevchenko National University of Kyiv, Ukraine.
Report Highlights
The global market for diabetes monitoring devices should grow from $19.7 billion in 2020 to $27.0 billion by 2025 with a compound annual growth rate (CAGR) of 6.5% for the period of 2020-2025.
Report Includes
- 29 data tables and 16 additional tables
- An overview of the global market for diabetes monitoring devices
- Estimation of the market size and analyses of global market trends, with data from 2019, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
- Detailed analysis of the current market trends, market forecast, and drivers and restraints of the industry
- Discussion on major developments and trends in innovative diabetes treatment technologies
- Detailed description of Self-Monitoring of Blood Glucose (SMBG) and Continuous Glucose Monitoring (CGM) Systems and examination of market structure, and history of these devices
- Identification of new opportunities, challenges, and technological changes within the industry and a look at the new products launches in the diabetes monitoring devices market
- Information on healthcare expenditure associated with diabetes and region wise statistical data presenting epidemiology and type of diabetes
- Company profiles of major players in the market including Abbott Laboratories, Becton, Dickinson and Co., Johnson & Johnson, Medtronic, Novo Nordisk A/S and Roche
Related Reports
Global Markets for Diabetes Therapeutics and Diagnostics
The global market for diabetes therapeutics and diagnostics is estimated to increase from $102.2 billion in 2023 to reach $132.0 billion by 2028, at a compound annual growth rate (CAGR) of 5.2% from 2023 through 2028.
AI in Diabetes Management: Global Market Outlook
This report presents an in-depth assessment of the global market outlook for artificial intelligence (AI) in diabetes management. The study includes AI in diabetes management care platforms and associated services. It covers the impact of macroeconomic factors affecting the global market for AI in diabetes management. The report examines emerging market trends, and underlying future opportunities in the market. The report concludes with the company profiles of leading market participants and their offerings in AI in diabetes management products, solutions and services.
Type 2 Diabetes Treatment: Global Market Outlook
The goal is to provide an up-to-date analysis of the global type 2 diabetes treatment market and future opportunities in the market. It presents a thorough and up-to-date global assessment of the market and business of the type 2 diabetes treatment. This will help industry participants, suppliers, government bodies, associations, and customers make the informed decisions needed to compete and succeed in the marketplace. The scope of the study includes the various types of medicines involved in type 2 diabetes treatment and management. Blood glucose monitoring, diagnostic systems and devices, and insulin-delivery devices used in the treatment of type 2 diabetes, however, have been excluded from this study.
Recent Reports
2024 Medical Devices Research Review
The medical device industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years These devices treat and diagnose a multitude of patient conditions and work much better than drugs.
Global Diabetic Care Devices Market
The global market for diabetes monitoring devices is expected to grow from $16.6 billion in 2024 to $26.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.1% from 2024 through 2029.
Tissue Diagnostics: Technologies and Global Markets
The global market for tissue diagnostics is estimated to increase from $8.9 billion in 2024 to reach $12.4 billion by 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 through 2029.
Global Injectable Drug Delivery Devices Market
The global market for injectable drug delivery device is estimated to increase from $216.5 billion in 2024 to reach $317.2 billion by 2029, at a compound annual growth rate (CAGR) of 7.9% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from $810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Carbon Capture, Utilization & Storage Technologies
The global market for carbon capture, utilization and storage (CCUS) technologies is expected to grow from $3.4 billion in 2024 and is projected to reach $9.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.1% during the forecast period of 2024 to 2029.
Cell-Based Assays: Technologies and Global Markets
The global market for cell-based assays is estimated to increase from $35.3 billion in 2024 to reach $56.3 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Generative AI: Global Markets
The global market for generative AI was valued at $15.4 billion in 2023. It is projected to grow from $20.8 billion in 2024 to $94.4 billion by 2029, at a compound annual growth rate (CAGR) of 35.3% from 2024 through 2029.
Global Markets for Chemicals for Cosmetics & Toiletries
The global market for chemicals in cosmetics and toiletries is expected to grow from $27.7 billion in 2024 to $35.0 billion by 2029, at a compound annual growth rate (CAGR) of 4.8% from 2024 through 2029.
Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets
The global market for liquid biopsy is expected to grow from $4.6 billion in 2024 and is projected to reach $13.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.3% during the forecast period of 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More